These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10396659)

  • 1. Glaucoma secondary to topical use of steroid cream.
    thoe Schwartzenberg GW; Buys YM
    Can J Ophthalmol; 1999 Jun; 34(4):222-5. PubMed ID: 10396659
    [No Abstract]   [Full Text] [Related]  

  • 2. Halcinonide, a new topical anti-inflammatory steroid.
    Savin RC
    J Int Med Res; 1976; 4(1):34-6. PubMed ID: 799976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of a modified hydrocortisone/urea cream and betamethasone valerate cream in the treatment of dry eczema.
    Williamson DM
    J Int Med Res; 1987; 15(2):99-105. PubMed ID: 3582724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of 0.3% diflucortolone valerate in the topical treatment of steroid-sensitive dermatitis].
    Jucci A; Fideli D; Speziali A
    G Ital Dermatol Venereol; 1986; 121(6):LXXVII-LXXX. PubMed ID: 3549546
    [No Abstract]   [Full Text] [Related]  

  • 5. Systemic side-effects of three topical steroids in diseased skin.
    Salde L; Lassus A
    Curr Med Res Opin; 1983; 8(7):475-80. PubMed ID: 6226490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trial comparing hydrocortisone 17-butyrate to betamethasone 17-valerate in a series of patients with eczematous skin diseases.
    Thormann J; Brodthagen H
    Dermatologica; 1976; 152 Suppl 1():209-14. PubMed ID: 782955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 0.25% prednicarbate cream and the corresponding vehicle induce less skin atrophy than 0.1% betamethasone-17-valerate cream and 0.05% clobetasol-17-propionate cream.
    Korting HC; Vieluf D; Kerscher M
    Eur J Clin Pharmacol; 1992; 42(2):159-61. PubMed ID: 1618247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind comparison of 0.25% and 0.05% desoxymethasone, 0.1% betamethasone valerate and 1% hydrocortisone creams in the treatment of eczema.
    Ashton RE; Catterall M; Morley N; Fairris G; Joseph DN
    J Int Med Res; 1987; 15(3):160-6. PubMed ID: 3301455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical treatment with urea-hydrocortisone in atopic dermatitis. A controlled study against betamethasone 17-valerate.
    Laurberg G
    Dermatologica; 1975; 151(1):30-3. PubMed ID: 1107090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glaucoma from topical corticosteroids to the eyelids.
    Garrott HM; Walland MJ
    Clin Exp Ophthalmol; 2004 Apr; 32(2):224-6. PubMed ID: 15068445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linear extensions of hypopigmentation as a side effect of topical corticosteroid application.
    Kwon HH; Suh DH
    Int J Dermatol; 2016 May; 55(5):e315-7. PubMed ID: 26756396
    [No Abstract]   [Full Text] [Related]  

  • 12. Glaucoma induced by periorbital topical steroid use--a rare complication.
    Sahni D; Darley CR; Hawk JL
    Clin Exp Dermatol; 2004 Nov; 29(6):617-9. PubMed ID: 15550136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic uses of halcinonide.
    Beveridge GW
    Scott Med J; 1977 Jul; 22(3):231-3. PubMed ID: 329412
    [No Abstract]   [Full Text] [Related]  

  • 14. Diflucortolone valerate (Nerisona): a comparative vasoconstriction test in artificially induced hyperemia of the skin.
    Reckers R; Wendt H
    Clin Ther; 1980; 3(3):190-3. PubMed ID: 7459929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steroid glaucoma.
    Miller SJ
    Trans Ophthalmol Soc U K (1962); 1965; 85():289-94. PubMed ID: 5227190
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of the base on the results of clinical trials with topical corticosteroids.
    Vollum DI; Sparkes CG
    Dermatologica; 1979; 158(4):293-8. PubMed ID: 372027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of tinea pedis with a topical agent containing isoconazole nitrate and diflucortolone valerate.
    Kye YC
    Mycoses; 2008 Sep; 51 Suppl 4():48-9. PubMed ID: 18783570
    [No Abstract]   [Full Text] [Related]  

  • 18. [Fluocinonid--a new corticoid for the dermatologic local therapy].
    Weitgasser H
    Z Haut Geschlechtskr; 1972 Mar; 47(6):231-4. PubMed ID: 5019023
    [No Abstract]   [Full Text] [Related]  

  • 19. Once daily application of diflorasone diacetate ointment compared with betamethasone valerate ointment twice daily in patients with eczematous dermatoses.
    Hersle K; Mobacken H
    J Int Med Res; 1982; 10(6):423-5. PubMed ID: 7152081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Multicentre-clinical trial of the novel corticosteroid diflucortolone valerate in the forms of cream, ointment and fatty ointment. Part II: Comparative study with several commercial preparations (author's transl)].
    Reckers VR; Wendt H
    Arzneimittelforschung; 1976; 26(7b):1504-9. PubMed ID: 795434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.